Evaluation of a Noninvasive Fetal RHD Genotyping Test
NCT01054716 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2011-09-05
Summary
This study will collect whole blood samples from pregnant subjects who are RhD negative by serology to develop an assay for RHD determination of the fetus.
Conditions
- Rhesus D Genotype
Sponsors & Collaborators
-
Sequenom Center for Molecular Medicine
collaborator UNKNOWN -
Sequenom, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2010-11-30
- Completion
- 2010-11-30
Countries
- United States
Study Locations
More Related Trials
-
Fetal RhD Genotye Non Invasive Prenatal Determination
NCT02788383 ·Status: UNKNOWN
-
Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders
NCT02339402 ·Status: UNKNOWN
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Perinatal Precision Medicine
NCT03211039 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Development of a Fetal Sex Assay From Maternal Whole Blood
NCT00970047 ·Status: COMPLETED
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis
NCT02255825 ·Status: WITHDRAWN ·Phase: NA
-
Whole Blood Specimen Collection From Pregnant Subjects
NCT02430584 ·Status: UNKNOWN
-
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
NCT04595201 ·Status: RECRUITING
-
A New Prenatal Blood Test for Down Syndrome
NCT00877292 ·Status: COMPLETED
-
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
NCT01597063 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Collection of Whole Blood Specimens in Pregnant Women
NCT03590678 ·Status: COMPLETED
-
Doppler or Amniocentesis to Predict Fetal Anemia
NCT00295516 ·Status: COMPLETED ·Phase: PHASE3
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
Prenatal Genetic Diagnosis by Genomic Sequencing
NCT03936101 ·Status: COMPLETED
-
Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
NCT06147414 ·Status: RECRUITING
-
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781 ·Status: COMPLETED
-
Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.
NCT02969174 ·Status: APPROVED_FOR_MARKETING
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688 ·Status: COMPLETED
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
Human Anti-D (rh) Immunoglobulin (Rhesoglobin) Efficacy, Safety and Some Pharmacokinetics Parameters in Pregnant Women
NCT05245734 ·Status: RECRUITING ·Phase: PHASE4
-
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
NCT06808880 ·Status: RECRUITING